Bellevue Healthcare Trust plc: Issue of Ordinary Shares: Difference between revisions

No edit summary
No edit summary
Line 1: Line 1:
{{Cover Image|[[File:Bellevue Healthcare Trust plc update new shares.jpg]]}}
On the 12th May 2022, Bellevue Healthcare Trust plc (the "Company") announced that it has today issued 400,000 of its ordinary shares of one penny each ("Ordinary Shares") pursuant to its block listing facility in two tranches. The Ordinary Shares will be issued at the price per Ordinary Share detailed below which represent a premium to the prevailing net asset value ("cum income") per Ordinary Share:
On the 12th May 2022, Bellevue Healthcare Trust plc (the "Company") announced that it has today issued 400,000 of its ordinary shares of one penny each ("Ordinary Shares") pursuant to its block listing facility in two tranches. The Ordinary Shares will be issued at the price per Ordinary Share detailed below which represent a premium to the prevailing net asset value ("cum income") per Ordinary Share:
{| class="wikitable"
{| class="wikitable"

Revision as of 14:26, 3 September 2022

Bellevue Healthcare Trust plc update new shares.jpg

On the 12th May 2022, Bellevue Healthcare Trust plc (the "Company") announced that it has today issued 400,000 of its ordinary shares of one penny each ("Ordinary Shares") pursuant to its block listing facility in two tranches. The Ordinary Shares will be issued at the price per Ordinary Share detailed below which represent a premium to the prevailing net asset value ("cum income") per Ordinary Share:

Ordinary Shares issued Price per Ordinary Share
200,000 146.20 pence
200,000 147.21 pence

Following the issue of Ordinary Shares, the Company's issued share capital will comprise (581,537,380) Ordinary Shares and this is the total number of Ordinary Shares with voting rights in the Company. This figure (581,537,380) may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to, their interest in the Company under the Financial Conduct Authority's Disclosure Guidance and Transparency Rules.

References and notes

The company.